ArticleMedical devices (Auckland, N.Z.)2021

An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy.

Aino Fianu Jonasson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.